Celemics

Celemics ROIC

The Return on Invested Capital (ROIC) of Celemics (331920.KQ) as of Oct 29, 2026 is -17.54 %. In the previous year, Return on Invested Capital (ROIC) was 44.82 % — a change of -139.12% (lower).

ROIC

-17.54 %

YoY

-139.12%

Last updated:

Return on Invested Capital (ROIC) of Celemics is 2025 -17.54 % . Return on Invested Capital (ROIC) of Celemics was 2024 44.82 % . It decreases by -139.12% lower compared to the previous year.

The Celemics ROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROIC
Date
ROIC
Jan 1, 2018
131.37 KRW
Jan 1, 2019
-37.09 KRW
Jan 1, 2020
-16.04 KRW
Jan 1, 2021
-21.25 KRW
Jan 1, 2022
-24.62 KRW
Jan 1, 2023
-23.59 KRW
Jan 1, 2024
44.82 KRW
Jan 1, 2025
-17.54 KRW
The Celemics ROIC history
YEARROICYoY
-17.54 %-139.12%
44.82 %-289.99%
-23.59 %-4.16%
-24.62 %+15.83%
-21.25 %+32.48%
-16.04 %-56.75%
-37.09 %-128.24%
131.37 %+26.59%
103.77 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Celemics Stock analysis

What does Celemics do? Celemics Inc is a South Korean company based in Seoul, operating within the Health Care sector, specifically in the Life Sciences Tools & Services industry. The company provides biotechnology services, focusing on the development and sale of target capture kit products. It also offers immune repertoire analysis solutions and next-generation sequencing solutions. Celemics Inc went public through an IPO on August 21, 2020, and currently employs 63 full-time staff. The company's products are sold in both domestic and international markets. Its headquarters are located in Seoul, South Korea, and it maintains a website at www.celemics.com. The firm's primary business activities include the provision of specialized biotechnology services, with an emphasis on innovative tools and solutions for life science research and applications. Celemics Inc has a presence in the Korean market and extends its reach to global customers, supporting various research and diagnostic needs through its technology-driven services. The company's operational focus remains on developing and delivering advanced biotechnology solutions to meet the evolving demands of the life sciences industry. Celemics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Celemics stock

Return on Invested Capital (ROIC) of Celemics is -17.54 % in 2025.

Return on Invested Capital (ROIC) of Celemics changed from 44.82 % to -17.54 %, representing a -139.12% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Invested Capital (ROIC) Celemics since 2006 – with annual values, charts, and detailed analysis.

ROIC measures how effectively a company uses its invested capital to generate profits. A ROIC above the cost of capital creates shareholder value.

ROIC = NOPAT / Invested Capital

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Invested Capital (ROIC)'s Celemics with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Invested Capital (ROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Invested Capital (ROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Celemics

All Key Metrics — Celemics